Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-09
DOI
10.1007/s00262-020-02725-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
- (2020) Yuying Liu et al. Science Immunology
- Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19
- (2020) Sangya Agarwal et al. Cancer Discovery
- COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis
- (2020) Robert Lorenz Chua et al. NATURE BIOTECHNOLOGY
- Comprehensive mapping of immune perturbations associated with severe COVID-19
- (2020) Leticia Kuri-Cervantes et al. Science Immunology
- Comprehensive Immune Monitoring of Clinical Trials to Advance Human Immunotherapy
- (2019) Felix J. Hartmann et al. Cell Reports
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
- (2018) Margherita Norelli et al. NATURE MEDICINE
- CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
- (2018) Theodoros Giavridis et al. NATURE MEDICINE
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and Biologic Correlates of Neurotoxicity Associated with CAR T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia (B-ALL)
- (2018) Bianca D. Santomasso et al. Cancer Discovery
- Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1–Based Immunotherapy
- (2018) Su Y. Lim et al. CLINICAL CANCER RESEARCH
- Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials
- (2018) Y. Kanjanapan et al. EUROPEAN JOURNAL OF CANCER
- Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome
- (2018) Verena Staedtke et al. NATURE
- Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
- (2017) S. Cuzzubbo et al. EUROPEAN JOURNAL OF CANCER
- Is autoimmunity the Achilles' heel of cancer immunotherapy?
- (2017) Carl H June et al. NATURE MEDICINE
- Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
- (2017) Juliane Gust et al. Cancer Discovery
- Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire
- (2016) David Y. Oh et al. CANCER RESEARCH
- Molecular Pathways: Immune Checkpoint Antibodies and their Toxicities
- (2016) S. Cousin et al. CLINICAL CANCER RESEARCH
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
- (2016) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- Neurological sequelae of cancer immunotherapies and targeted therapies
- (2016) Wolfgang Wick et al. LANCET ONCOLOGY
- Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
- (2016) Sumit K. Subudhi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
- (2016) D. T. Teachey et al. Cancer Discovery
- Immunologic Correlates in the Course of Treatment With Immunomodulating Antibodies
- (2015) Benjamin Weide et al. SEMINARS IN ONCOLOGY
- Current concepts in the diagnosis and management of cytokine release syndrome
- (2014) D. W. Lee et al. BLOOD
- Th1, Th2, and Th17 Effector T Cell-Induced Autoimmune Gastritis Differs in Pathological Pattern and in Susceptibility to Suppression by Regulatory T Cells
- (2014) G. H. Stummvoll et al. JOURNAL OF IMMUNOLOGY
- Erythropoietin Attenuates Lung Injury in Lipopolysaccharide Treated Rats
- (2008) You Shang et al. JOURNAL OF SURGICAL RESEARCH
- A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses
- (2008) Elisabetta Volpe et al. NATURE IMMUNOLOGY
- Erythropoietin: A Potent Inducer of Peripheral Immuno/Inflammatory Modulation in Autoimmune EAE
- (2008) RuiRong Yuan et al. PLoS One
- Immunity and cognition: what do age-related dementia, HIV-dementia and ‘chemo-brain’ have in common?
- (2008) Jonathan Kipnis et al. TRENDS IN IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started